Characterization of Interleukin-33 and Soluble ST2 in Serum and Their Association with Disease Severity in Patients with Chronic Kidney Disease

被引:0
|
作者
Yu-Shi Bao
Shi-Ping Na
Ping Zhang
Xi-Bei Jia
Rui-Chan Liu
Cheng-Yuan Yu
Su-Hong Mu
Ru-Juan Xie
机构
[1] The First Affiliated Hospital of Harbin Medical University,Department of Nephrology
[2] Harbin Medical University,Department of Hematology
[3] Provincial Hospital Affiliated to Shandong University,undefined
来源
Journal of Clinical Immunology | 2012年 / 32卷
关键词
Interleukin-33; soluble ST2; chronic kidney disease; immune response;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:587 / 594
页数:7
相关论文
共 50 条
  • [41] Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still's Disease
    Han, Jae Ho
    Suh, Chang-Hee
    Jung, Ju-Yang
    Ahn, Hyun
    Kwon, Ji Eun
    Yim, Hyunee
    Kim, Hyoun-Ah
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 740 - 747
  • [42] The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox
    Allegra, Alessandro
    Innao, Vanessa
    Tartarisco, Gennaro
    Pioggia, Giovanni
    Casciaro, Marco
    Musolino, Caterina
    Gangemi, Sebastiano
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (20)
  • [43] Serum Levels of Soluble ST2 and IL-10 Are Associated with Disease Severity in Patients with IgA Nephropathy
    Zhang, Zhihui
    Wang, Haifeng
    Zhang, Li
    Crew, Rebecca
    Zhang, Nan
    Liu, Xiaolei
    Jiang, Yanfang
    JOURNAL OF IMMUNOLOGY RESEARCH, 2016, 2016
  • [44] Plasma levels of soluble ST2, but not IL-33, correlate with the severity of alcoholic liver disease
    Sun, Zijian
    Chang, Binxia
    Huang, Ang
    Hao, Shuli
    Gao, Miaomiao
    Sun, Ying
    Shi, Ming
    Jin, Lei
    Zhang, Wei
    Zhao, Jun
    Teng, Guangju
    Han, Lin
    Tian, Hui
    Liang, Qingsheng
    Zhang, Ji-Yuan
    Zou, Zhengsheng
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (02) : 887 - 897
  • [45] Correlation of Interleukin-33/ST2 Receptor and Liver Fibrosis Progression in Biliary Atresia Patients
    Liu, Jia
    Yang, YiFan
    Zheng, Chao
    Chen, Gong
    Shen, Zhen
    Zheng, Shan
    Dong, Rui
    FRONTIERS IN PEDIATRICS, 2019, 7
  • [46] The role of the Interleukin 1 receptor-like 1 (ST2) and Interleukin-33 pathway in cardiovascular disease and cardiovascular risk assessment
    Willems, S.
    Hoefer, I.
    Pasterkamp, G.
    MINERVA MEDICA, 2012, 103 (06) : 513 - 523
  • [47] INTERLEUKIN-33 REGULATES THE DEVELOPMENT OF INFLAMMATORY BOWEL DISEASE THROUGH ITS RECEPTOR ST2 IN ENTERIC GLIAL CELLS
    Nie, Kai
    Yang, Yuanyuan
    Wang Xiaoyan
    GASTROENTEROLOGY, 2022, 162 (07) : S979 - S980
  • [48] Interleukin-33/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli
    Shimpei Yamada
    Masaki Shimizu
    Mondo Kuroda
    Natsumi Inoue
    Naotoshi Sugimoto
    Akihiro Yachie
    Clinical and Experimental Nephrology, 2019, 23 : 544 - 550
  • [49] Interleukin-33/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli
    Yamada, Shimpei
    Shimizu, Masaki
    Kuroda, Mondo
    Inoue, Natsumi
    Sugimoto, Naotoshi
    Yachie, Akihiro
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2019, 23 (04) : 544 - 550
  • [50] KEY ROLE OF INTERLEUKIN-33/ST2 SIGNALLING IN THE PATHOGENESIS OF LIVER FIBROSIS
    Mchedlidze, T.
    Pflanz, S.
    Neurath, M. F.
    Wirtz, S.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S53 - S53